• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子风暴通路在病毒性呼吸道大流行临床过程中的潜在作用

The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic.

作者信息

Murdaca Giuseppe, Paladin Francesca, Tonacci Alessandro, Isola Stefania, Allegra Alessandro, Gangemi Sebastiano

机构信息

Clinical Immunology Unit, Department of Internal Medicine, University of Genoa and Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Department of Internal Medicine, University of Genoa and Ospedale Policlinico San Martino, 16132 Genoa, Italy.

出版信息

Biomedicines. 2021 Nov 15;9(11):1688. doi: 10.3390/biomedicines9111688.

DOI:10.3390/biomedicines9111688
PMID:34829918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8615478/
Abstract

The "cytokine storm" (CS) consists of a spectrum of different immune dysregulation disorders characterized by constitutional symptoms, systemic inflammation and multiorgan dysfunction triggered by an uncontrolled immune response. Particularly in respiratory virus infections, the cytokine storm plays a primary role in the pathogenesis of respiratory disease and the clinical outcome of respiratory diseases, leading to complications such as alveolar edema and hypoxia. In this review, we wanted to analyze the different pathogenetic mechanisms involved in the various respiratory viral pandemics (COVID-19; SARS; MERS; H1N1 influenza A and Spanish flu) which have affected humans in this and last century, with particular attention to the phenomenon of the "cytokine storm" which determines the clinical severity of the respiratory disease and consequently its lethality.

摘要

“细胞因子风暴”(CS)由一系列不同的免疫失调疾病组成,其特征为全身症状、全身炎症以及由不受控制的免疫反应引发的多器官功能障碍。特别是在呼吸道病毒感染中,细胞因子风暴在呼吸道疾病的发病机制和临床结局中起主要作用,导致诸如肺泡水肿和缺氧等并发症。在本综述中,我们希望分析在本世纪和上世纪影响人类的各种呼吸道病毒性大流行(新冠病毒病、严重急性呼吸综合征、中东呼吸综合征、甲型H1N1流感和西班牙流感)中涉及的不同发病机制,尤其关注决定呼吸道疾病临床严重程度及其致死率的“细胞因子风暴”现象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce26/8615478/843009b96659/biomedicines-09-01688-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce26/8615478/68eafb0a8ce6/biomedicines-09-01688-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce26/8615478/2c6ab1f68c82/biomedicines-09-01688-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce26/8615478/843009b96659/biomedicines-09-01688-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce26/8615478/68eafb0a8ce6/biomedicines-09-01688-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce26/8615478/2c6ab1f68c82/biomedicines-09-01688-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce26/8615478/843009b96659/biomedicines-09-01688-g003.jpg

相似文献

1
The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic.细胞因子风暴通路在病毒性呼吸道大流行临床过程中的潜在作用
Biomedicines. 2021 Nov 15;9(11):1688. doi: 10.3390/biomedicines9111688.
2
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.靶向 SphK-S1P-SIPR 通路作为 COVID-19 的一种潜在治疗方法。
Int J Mol Sci. 2020 Sep 29;21(19):7189. doi: 10.3390/ijms21197189.
3
Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.新型冠状病毒肺炎中的低氧血症与细胞因子风暴:临床意义。
MEDICC Rev. 2021 Jul-Oct;23(3-4):54-59. doi: 10.37757/MR2021.V23.N3.10. Epub 2021 Aug 22.
4
Pathogenesis and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎细胞因子风暴的发病机制与治疗
Turk J Biol. 2021 Aug 30;45(4):372-389. doi: 10.3906/biy-2105-37. eCollection 2021.
5
[Cytokine storm in avian influenza].[禽流感中的细胞因子风暴]
Mikrobiyol Bul. 2008 Apr;42(2):365-80.
6
Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.针对重症 COVID-19 中炎症调节微小 RNA 的营养保健品靶向治疗:预防细胞因子风暴的新方法
Front Pharmacol. 2020 Dec 11;11:602999. doi: 10.3389/fphar.2020.602999. eCollection 2020.
7
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺,增加白细胞介素-1 水平,导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
8
COVID-19 Disease, Women's Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay.新型冠状病毒肺炎、女性为主的非肝素疫苗诱导的血栓性血小板减少症和库尼斯综合征:一种百通因子细胞因子风暴的相互作用
Biomedicines. 2021 Aug 5;9(8):959. doi: 10.3390/biomedicines9080959.
9
Cytokines and COVID-19: friends or foes?细胞因子与 COVID-19:是敌是友?
Hum Vaccin Immunother. 2020 Oct 2;16(10):2363-2365. doi: 10.1080/21645515.2020.1799669. Epub 2020 Aug 25.
10
COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings.COVID-19:发病机制、遗传多态性、临床特征和实验室发现。
Turk J Med Sci. 2020 Apr 21;50(SI-1):638-657. doi: 10.3906/sag-2005-287.

引用本文的文献

1
Host-Strain-Specific Responses to Pneumonia Virus of Mice Infection: A Study of Lesions, Viral Load, and Cytokine Expression.宿主菌株对小鼠肺炎病毒感染的特异性反应:病变、病毒载量和细胞因子表达的研究。
Viruses. 2025 Apr 9;17(4):548. doi: 10.3390/v17040548.
2
Stable Nitroxide as Diagnostic Tools for Monitoring of Oxidative Stress and Hypoalbuminemia in the Context of COVID-19.稳定氮氧化物作为 COVID-19 氧化应激和低白蛋白血症监测的诊断工具。
Int J Mol Sci. 2024 Jul 24;25(15):8045. doi: 10.3390/ijms25158045.
3
IFNAR(-/-) Mice Constitute a Suitable Animal Model for Epizootic Hemorrhagic Disease Virus Study and Vaccine Evaluation.

本文引用的文献

1
Basophils and Mast Cells in COVID-19 Pathogenesis.COVID-19 发病机制中的嗜碱性粒细胞和肥大细胞。
Cells. 2021 Oct 14;10(10):2754. doi: 10.3390/cells10102754.
2
SARS-CoV-2 Variants of Concern.关注的 SARS-CoV-2 变体。
Yonsei Med J. 2021 Nov;62(11):961-968. doi: 10.3349/ymj.2021.62.11.961.
3
Host genetic factors determining COVID-19 susceptibility and severity.决定新冠病毒易感性和严重程度的宿主遗传因素。
IFNAR(-/-) 小鼠可作为研究和评估流行性出血热病毒疫苗的合适动物模型。
Int J Biol Sci. 2024 May 27;20(8):3076-3093. doi: 10.7150/ijbs.95275. eCollection 2024.
4
HIF-1α promotes virus replication and cytokine storm in H1N1 virus-induced severe pneumonia through cellular metabolic reprogramming.低氧诱导因子 1α 通过细胞代谢重编程促进 H1N1 病毒诱导的重症肺炎中的病毒复制和细胞因子风暴。
Virol Sin. 2024 Feb;39(1):81-96. doi: 10.1016/j.virs.2023.11.010. Epub 2023 Nov 30.
5
Mesenchymal Stem Cells in the Treatment of COVID-19.间充质干细胞在治疗 COVID-19 中的作用。
Int J Mol Sci. 2023 Sep 30;24(19):14800. doi: 10.3390/ijms241914800.
6
Immunometabolic Signature during Respiratory Viral Infection: A Potential Target for Host-Directed Therapies.呼吸道病毒感染期间的免疫代谢特征:宿主定向治疗的潜在靶点。
Viruses. 2023 Feb 13;15(2):525. doi: 10.3390/v15020525.
7
The Impact of Curcumin on Immune Response: An Immunomodulatory Strategy to Treat Sepsis.姜黄素对免疫应答的影响:治疗脓毒症的免疫调节策略。
Int J Mol Sci. 2022 Nov 25;23(23):14710. doi: 10.3390/ijms232314710.
8
Therapeutic Potential of 2-Methylquinazolin-4(3H)-one as an Antiviral Agent against Influenza A Virus-Induced Acute Lung Injury in Mice.2-甲基喹唑啉-4(3H)-酮作为抗流感 A 病毒诱导的小鼠急性肺损伤的治疗潜力。
Molecules. 2022 Nov 14;27(22):7857. doi: 10.3390/molecules27227857.
9
N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions.N-乙酰半胱氨酸预防和治疗 COVID-19:现有证据和未来方向。
J Infect Public Health. 2022 Dec;15(12):1477-1483. doi: 10.1016/j.jiph.2022.11.009. Epub 2022 Nov 12.
10
Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.新型冠状病毒病 2019 与玫瑰糠疹:免疫关联的综述。
J Dermatol. 2022 Oct;49(10):948-956. doi: 10.1111/1346-8138.16482. Epub 2022 Jun 8.
EBioMedicine. 2021 Oct;72:103629. doi: 10.1016/j.ebiom.2021.103629. Epub 2021 Oct 13.
4
Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients.针对 PI3K/Akt/mTOR 通路:COVID-19 患者的一种治疗策略。
Immunol Lett. 2021 Dec;240:1-8. doi: 10.1016/j.imlet.2021.09.005. Epub 2021 Sep 23.
5
Lessons from the past in the present: news from the Spanish flu pandemic to COVID-19.从过去吸取教训应对当下:从西班牙流感大流行到 COVID-19 的新闻。
Rev Bras Enferm. 2021 Sep 6;75(1):e20201161. doi: 10.1590/0034-7167-2020-1161. eCollection 2021.
6
Evolutionary trajectory of SARS-CoV-2 and emerging variants.SARS-CoV-2 的进化轨迹和新兴变种。
Virol J. 2021 Aug 13;18(1):166. doi: 10.1186/s12985-021-01633-w.
7
Prolonged SARS-CoV2 Viral Shedding in an Elderly Patient.一名老年患者中SARS-CoV-2病毒的长期脱落
Cureus. 2021 May 19;13(5):e15128. doi: 10.7759/cureus.15128.
8
New variants of SARS-CoV-2.严重急性呼吸综合征冠状病毒2的新变种
Rev Esp Quimioter. 2021 Oct;34(5):419-428. doi: 10.37201/req/071.2021. Epub 2021 Jun 2.
9
Novel SARS-CoV-2 variants: the pandemics within the pandemic.新型 SARS-CoV-2 变体:大流行中的大流行。
Clin Microbiol Infect. 2021 Aug;27(8):1109-1117. doi: 10.1016/j.cmi.2021.05.022. Epub 2021 May 17.
10
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies.COVID-19 的传播、当前治疗方法和未来治疗策略。
Mol Pharm. 2021 Mar 1;18(3):754-771. doi: 10.1021/acs.molpharmaceut.0c00608. Epub 2021 Jan 19.